Retrospective cohort study reveals improved outcomes with left atrial appendage occlusion in kidney failure patients, suggesting its potential over anticoagulants.
Key Points
LAAO is associated with improved survival in patients with kidney failure and atrial fibrillation, reducing death rates compared to anticoagulants.
In the LAAO group, the hazard ratio for recurrent bleeding events was significantly lower, indicating a reduced risk compared to the anticoagulant group.
Patients who received LAAO experienced fewer total nonfatal strokes, although this finding was not significant after further adjustment.
Data suggests that LAAO may offer a safer alternative for patients with kidney failure at high risk for bleeding and strokes.